翻訳と辞書 |
Cantuzumab ravtansine : ウィキペディア英語版 | Cantuzumab ravtansine
Cantuzumab ravtansine (huC242-SPDB-DM4) is an antibody-drug conjugate designed for the treatment of cancers. The humanized monoclonal antibody ''cantuzumab'' (huC242) is linked to a cytotoxic agent, ravtansine (DM4). It uses a more hindered disulphide linkage than Cantuzumab mertansine.〔(Antibody-Drug Conjugates and Immunotoxins: From Pre-Clinical Development to ... )〕 == See also ==
* Cantuzumab mertansine * ImmunoGen Inc, developer of DM4 based drugs
抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「Cantuzumab ravtansine」の詳細全文を読む
スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|